This IBM Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Comments
Loading...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Goldman Sachs analyst Richard Law initiated coverage on Silence Therapeutics plc SLN with a Sell rating and announced a price target of $6. Silence Therapeutics shares closed at $4.92 on Monday. See how other analysts view this stock.
  • Roth MKM analyst George Kelly initiated coverage on Gaia, Inc. GAIA with a Buy rating and announced a price target of $10. Gaia shares closed at $5.00 on Monday. See how other analysts view this stock.
  • Goldman Sachs analyst Gerry Sweeney initiated coverage on AZZ Inc. AZZ with a Buy rating and announced a price target of $108. AZZ shares closed at $97.55 on Monday. See how other analysts view this stock.
  • Jefferies analyst Glen Santangelo initiated coverage on Waystar Holding Corp. WAY with a Buy rating and announced a price target of $51. Waystar shares closed at $41.45 on Monday. See how other analysts view this stock.
  • Oppenheimer analyst Param Singh initiated coverage on International Business Machines Corporation IBM with an Outperform rating and announced a price target of $320. IBM shares closed at $249.27 on Monday. See how other analysts view this stock.

Considering buying AZZ stock? Here’s what analysts think:

Read This Next:

AZZ Logo
AZZAZZ Inc
$81.801.19%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
81.13
Growth
81.89
Quality
79.86
Value
30.68
Price Trend
Short
Medium
Long
Got Questions? Ask
How might Silence Therapeutics react to a Sell rating?
Could Gaia, Inc. see significant growth from a Buy rating?
What factors will drive AZZ Inc. towards its new price target?
Is Waystar Holding Corp. well-positioned for a price surge?
What strategies could IBM employ to reach its price target?
Which sectors are influenced by analyst ratings changes?
How do buy ratings impact stock performance?
What could trigger a rebound for Silence Therapeutics?
Are there hidden gems in healthcare stocks after rating changes?
Which companies might face fallout from Sell ratings?
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Posted In: